Abstract
Circulating tumour cells (CTCs) constitute a potential tumour surrogate that could serve as “liquid biopsy” with the advantage to be a minimally invasive approach compared to traditional tissue biopsies. As CTCs are thought to be the source of metastatic lesions, their analysis represents a potential means of tracking cancer cells from the primary tumour en route to distant sites, thus providing valuable insights into the metastatic process. However, several problems, such as their rarity in the peripheral blood, the technical limitations of single-cell downstream analysis and their phenotypic variability, make CTC detection and molecular characterisation very challenging. Nevertheless, in the last decade, there has been an exponential increase of interest in the development of powerful cellular and molecular methodologies applied to CTCs. In this chapter, we focus on the recent advances of functional studies and molecular profiling of CTCs. We will also highlight the clinical relevance of CTC detection and enumeration, and discuss their potential as tumour biomarkers with special focus on lung cancer.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abbosh C, Birkbak NJ, Wilson GA, Jamal-Hanjani M, Constantin T, Salari R et al (2017) Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature 545(7655)
Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA et al (2014) Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158(5):1110–1122
Alix-Panabieres C, Pantel K (2014) Challenges in circulating tumour cell research. Nat Rev Cancer 14(9):623–631
Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C et al (2005) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with non. Clin Cancer Res 10(October):6897–6904
American Cancer S (2016) Cancer Facts & Figures 2016. Cancer Facts & Fig 2016:1–9
Baccelli I, Schneeweiss A, Riethdorf S, Stenzinger A, Schillert A, Vogel V et al (2013) Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol 31(6):539–544
Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S et al (2008) DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med 358(11):1118–1128
Carlsson A, Nair VS, Luttgen MS, Keu KV, Horng G, Vasanawala M et al (2014) Circulating tumor microemboli diagnostics for patients with non-small cell lung cancer. J Thorac Oncol: Off Publ Int Assoc Study Lung Cancer. 9(8):1111–1119. PubMed PMID: PMC4145608
Carter L, Rothwell DG, Mesquita B, Smowton C, Leong HS, Fernandez-Gutierrez F et al (2016) Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer. Nat Med 23(November)
Cayrefourcq L, Mazard T, Joosse S, Solassol J, Ramos J, Assenat E et al (2015) Establishment and characterization of a cell line from human Circulating colon cancer cells. Can Res 75(5):892–901
Chen C-L, Mahalingam D, Osmulski P, Jadhav RR, Wang C-M, Leach RJ et al (2013) Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer. Prostate 73(8):813–826
Chimonidou M, Strati A, Malamos N, Kouneli S (2017) Direct comparison study of DNA methylation markers in EpCAM- positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancer
Chudziak J, Burt DJ, Mohan S, Rothwell DG, Mesquita B, Antonello J et al (2016) Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells in patients with small cell lung cancer. Analyst 141(2):669–78. PubMed PMID: 26605519. Epub 2015/11/26. eng
Cohen SJ, Punt CJA, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY et al (2008) Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 26(19):3213–3221
Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC et al (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351(8):781–791
Crosbie PA, Shah R, Krysiak P, Zhou C, Morris K, Tugwood J et al (2016) Circulating tumor cells detected in the tumor-draining pulmonary vein are associated with disease recurrence after surgical resection of NSCLC. J Thorac Oncol 11(10):1793–1797
de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H et al (2008) Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 14(19):6302–6309
de Bruin EC, McGranahan N, Mitter R, Salm M, Wedge DC, Yates L et al (2014) Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science 346(6206):251–256
Dean FB, Hosono S, Fang L, Wu X, Faruqi AF, Bray-Ward P et al (2002) Comprehensive human genome amplification using multiple displacement amplification. Proc Natl Acad Sci 99(8):5261–5266
Dong X, Zhang L, Milholland B, Lee M, Maslov AY, Wang T et al (2017) Accurate identification of single-nucleotide variants in whole-genome-amplified single cells. Nat Methods 20(10)
Dorsey JF, Kao GD, Macarthur KM, Ju M, Steinmetz D, Paul E et al (2015) Tracking viable circulating tumor cells (CTCs) in the peripheral blood of non-small cell lung cancer patients undergoing definitive radiation therapy: pilot study results. Cancer 121(1):139–149
Du Y-J, Li J, Zhu W-F, Wu Y, Tang X-P, Wang Y et al (2014) Survivin mRNA-circulating tumor cells predict treatment efficacy of chemotherapy and survival for advanced non-small cell lung cancer patients. Tumour Biol: J Int Soc Oncodevelopmental Biol Med 35(5):4499–4507
Faugeroux V, Pailler E, Auger N, Taylor M, Farace F (2014) Clinical utility of circulating tumor cells in ALK-positive non-small-cell lung cancer. Front Oncol 4(281)
Fiorelli A, Accardo M, Carelli E, Angioletti D, Santini M, Di Domenico M (2015) Circulating tumor cells in diagnosing lung cancer: clinical and morphologic analysis. Ann Thorac Surg 99(6):1899–1905
Gawad C, Koh W, Quake SR (2016) Single-cell genome sequencing: current state of the science. Nat Rev Genet 17(3):175–188
Girotti MR, Gremel G, Lee R, Galvani E, Rothwell D, Viros A et al (2016 ) Application of sequencing, liquid biopsies, and patient-derived xenografts for personalized medicine in melanoma. Cancer Discov 6(3):286–99. PubMed PMID: ISI:000373439500024. English
Grillet F, Bayet E, Villeronce O, Zappia L, Lagerqvist EL, Lunke S et al (2017) Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture. Gut 66(10):1802–1810
He J, Tan W, Ma J (2017) Circulating tumor cells and DNA for real-time EGFR detection and monitoring of non-small-cell lung cancer
Heitzer E, Auer M, Gasch C, Pichler M, Ulz P, Hoffmann EM et al (2013) Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Can Res 73(10):2965
Hodgkinson CL, Morrow CJ, Li Y, Metcalf RL, Rothwell DG, Trapani F et al (2014) Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer. Nat Med 20(8):897–903
Hofman V, Bonnetaud C Fau-Ilie MI, Ilie Mi Fau-Vielh P, Vielh P Fau-Vignaud JM, Vignaud Jm Fau-Flejou JF, Flejou Jf Fau-Lantuejoul S et al (2011) Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker. Clin Cancer Res 20110217 DCOM- 20110815(1078–0432 (Print)). eng
Hofman VJ, Ilie M, Hofman PM (2016) Detection and characterization of circulating tumor cells in lung cancer: Why and how? Cancer Cytopathol 124(6):380–387
Hou JM, Krebs MG, Lancashire L, Sloane R, Backen A, Swain RK et al (2012) Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol 30(5):525–532
Ilie M, Hofman V, Long-Mira E, Selva E, Vignaud JM, Padovani B et al (2014) “Sentinel” circulating tumor cells allow early diagnosis of lung cancer in patients with Chronic obstructive pulmonary disease. PLoS ONE 9(10):4–10
Jamal-hanjani M, Hackshaw A, Ngai Y, Shaw J, Dive C, Quezada S et al (2014) Tracking genomic cancer evolution for precision medicine: the lung TRACERx Study 12(7)
Jones PA (2012) Functions of DNA methylation: Islands, start sites, gene bodies and beyond. Nat Rev Genet 13(7):484–492
Juan O, Vidal J, Gisbert R, Muñoz J, Maciá S, Gómez-Codina J (2014) Prognostic significance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabine. Clin Transl Oncol 16(7):637–643
Klameth L, Rath B, Hochmaier M, Moser D, Redl M, Mungenast F et al (2017) Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance. Sci Rep 7(1):5337
Klein CA, Schmidt-Kittler O, Schardt JA, Pantel K, Speicher MR, Riethmüller G (1999) Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc Natl Acad Sci 96(8):4494–4499
Klein CA, Seidl S, Petat-Dutter K, Offner S, Geigl JB, Schmidt-Kittler O et al (2002) Combined transcriptome and genome analysis of single micrometastatic cells. Nat Biotech. 20(4):387–392
Kolostova K, Zhang Y, Hoffman RM, Bobek V (2014a) In vitro culture and characterization of human lung cancer circulating tumor cells isolated by size exclusion from an orthotopic nude-mouse model expressing fluorescent protein. J Fluoresc 24(5):1531–1536
Kolostova K, Broul M, Schraml J, Cegan M, Matkowski R, Fiutowski M et al (2014b) Circulating tumor cells in localized prostate cancer: Isolation, cultivation In Vitro and relationship to T-stage and gleason score. Anticancer Res 34(7):3641–3646
Kowalik A, Kowalewska M, Gozdz S (2017) Current approaches for avoiding the limitations of circulating tumor cells detection methods-implications for diagnosis and treatment of patients with solid tumors. Transl Res 185:58–84 e15. PubMed PMID: 28506696. Epub 2017/05/17. eng
Krebs MG, Sloane R, Priest L, Lancashire L, Hou JM, Greystoke A et al (2011) Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol 29(12):1556–1563
Krebs MG, Hou JM, Sloane R, Lancashire L, Priest L, Nonaka D et al (2012) Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J Thorac Oncol 7(2):306–315
Lallo A, Schenk MW, Frese KK, Blackhall F, Dive C (2017) Circulating tumor cells and CDX models as a tool for preclinical drug development. Transl Lung Cancer Res 6(4):397–408
Larson CJ, Moreno JG, Pienta KJ, Gross S, Repollet M, O’Hara SM et al (2004) Apoptosis of circulating tumor cells in prostate cancer patients. Cytometry Part A. 62(1):46–53
Lee CK, Brown C, Gralla RJ, Hirsh V, Thongprasert S, Tsai CM et al (2013) Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis. J Natl Cancer Inst 105(9):595–605
Lohr JG, Adalsteinsson VA, Cibulskis K, Choudhury AD, Rosenberg M, Cruz-Gordillo P et al (2014) Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer. Nat Biotech 32(5):479–484
Lu Y, Li SS, Zhu SS, Gong YY, Shi JJ, Xu LL (2017) Methylated DNA/RNA in Body Fluids as Biomarkers for Lung Cancer. Biol Proced Online 19:2
Magbanua MJM, Park JW (2014) Advances in genomic characterization of circulating tumor cells. Cancer Metastasis Rev 33(2–3):757–759
Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Brannigan B, Collura CV et al (2008) Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 359(4):366–377 PubMed PMID: 18596266
Man Y, Cao J, Jin S, Xu G, Pan B, Shang L et al (2014) Newly identified biomarkers for detecting circulating tumor cells in lung adenocarcinoma. Tohoku J Exp Med 234(1):29–40
Marchetti A, Del Grammastro M, Felicioni L, Malatesta S, Filice G, Centi I et al (2014) Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment. PLoS ONE 9(8):e103883
Milaki G, Messaritakis I, Koinis F, Kotsakis A, Apostolaki S, Dermitzaki EK et al (2017) Prognostic value of chemotherapy-resistant CK19mRNA-positive circulating tumor cells in patients with advanced/metastatic non-small cell lung cancer. Cancer Chemother Pharmacol 80(1):101–108
Miyamoto DT, Zheng Y, Wittner BS, Lee RJ, Zhu H, Broderick KT et al (2015) RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance. Science 349(6254):1351–1356
Miyamoto DT, Lee RJ, Kalinich M, LiCausi J, Zheng Y, Chen T et al (2018) An RNA-based digital circulating tumor cell signature is predictive of drug response and early dissemination in prostate cancer. Cancer Discov
Mohan S, Chemi F, Brady G (2017) Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer. Transl Lung Cancer Res 6(4):454–472
Morrow CJ, Trapani F, Metcalf RL, Bertolini G, Hodgkinson CL, Khandelwal G et al (2016) Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study. Ann Oncol 27(6):1155–1160
Muinelo-Romay L, Vieito M, Abalo A, Nocelo MA, Baron F, Anido U et al (2014) Evaluation of circulating tumor cells and related events as prognostic factors and surrogate biomarkers in advanced NSCLC patients receiving first-line systemic treatment. Cancers 6(1):153–165
Muller V, Stahmann N, Riethdorf S, Rau T, Zabel T, Goetz A et al (2005) Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res 11(10):3678–3685
Naito T, Tanaka F, Ono A, Yoneda K, Takahashi T, Murakami H et al (2012) Prognostic impact of circulating tumor cells in patients with small cell lung cancer. J Thorac Oncol 7(3):512–519
Nalejska E, Maczynska E, Lewandowska MA (2014) Prognostic and predictive biomarkers: tools in personalized oncology. Mol Diagn Ther. 18(3):273–284
Navin NE (2015) The first five years of single-cell cancer genomics and beyond. Genome Res 25
Nel I, Jehn U, Gauler T, Hoffmann A-C (2014) Individual profiling of circulating tumor cell composition in patients with non-small cell lung cancer receiving platinum based treatment. Transl Lung Cancer Res 3(2):100–106
Ni X, Zhuo M, Su Z, Duan J, Gao Y, Wang Z et al (2013) Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc Natl Acad Sci 110(52):21083–21088
Nicolazzo C, Cristina R, Mancini M, Caponnetto S, Gradilone A, Gandin O et al (2016) Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab. Sci Rep (6):31726
Offin M, Chabon JJ, Razavi P, Isbell JM, Rudin CM, Diehn M et al (2017) Capturing genomic evolution of lung cancers through liquid biopsy for circulating tumor DNA. J Oncol. 2017(Figure 1):1–5
O’Flaherty JD, Gray S, Richard D, Fennell D, O’Leary JJ, Blackhall FH et al (2012) Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer. Lung Cancer 76(1):19–25
O’Hara SM, Smirnov DA, Zweitzig DR, Foulk BW, Doyle GV, Pienta KJ et al (2005) Global gene expression profiling of circulating tumor cells. Proc Am Assoc Cancer Res Annu Meet 46(12):1311
Pailler E, Adam J, Barthelemy A, Oulhen M, Auger N, Valent A et al (2013) Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer. J Clin Oncol 31(18):2273–2281
Pailler E, Auger N, Lindsay CR, Vielh P, Islas-Morris-Hernandez A, Borget I et al (2015) High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer. Ann Oncol 26(7):1408–1415
Pailler E, Oulhen M, Borget I, Remon J, Ross K, Auger N et al (2017) Circulating tumor cells with aberrant ALK copy number predict progression-free survival during crizotinib treatment in ALK-rearranged non-small cell lung cancer patients. Can Res 77(9):2222–2230
Paoletti C, Cani AK, Larios JM, Hovelson DH, Aung K, Darga EP et al (2018) Comprehensive mutation and copy number profiling in archived circulating breast cancer tumor cells documents heterogeneous resistance mechanisms. Cancer Res 78(4):1110–1122. PubMed PMID: 29233927. Pubmed Central PMCID: PMC5815882. Epub 2017/12/14. eng
Peeters DJ, De Laere B, Van den Eynden GG, Van Laere SJ, Rothe F, Ignatiadis M et al (2013) Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from Cell Search enriched blood samples using dielectrophoretic cell sorting. Br J Cancer 108(6):1358–1367
Perakis S, Speicher MR (2017) Emerging concepts in liquid biopsies. BMC Med 15(1):017–0840
Pixberg CF, Raba K, Muller F, Behrens B, Honisch E, Niederacher D et al (2017) Analysis of DNA methylation in single circulating tumor cells. Oncogene
Punnoose EA, Atwal S, Liu W, Raja R, Fine BM, Hughes BGM et al (2012) Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib. Clin Cancer Res 18(8):2391
Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F et al (2012) EMT and dissemination precede pancreatic tumor formation. Cell 148(1–2):349–361
Rothwell DG, Smith N, Morris D, Leong HS, Li Y, Carter L et al (2015) Molecular characterisation of SCLC using both circulating tumour DNA and circulating tumour cells isolated from the same whole blood sample. J Thorac Oncol 10(9):S344-S
Sato T, Arai E, Kohno T, Takahashi Y, Miyata S, Tsuta K et al (2014) Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary disease. Int J Cancer 135(2):319–334
Schmidt-hansen M, Berendse S, Hamilton W, Baldwin DR (2017) Lung cancer in symptomatic patients presenting in primary care: a systematic review of risk prediction tools
Shaw AT, Yeap BY, Solomon BJ, Riely GJ, Gainor J, Engelman JA et al (2011) Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis. Lancet Oncol 12(11):1004–1012
Siegmund K, Shibata D (2016) At least two well-spaced samples are needed to genotype a solid tumor. BMC Cancer 16(1):250
Sieuwerts AM, Kraan J, Bolt-De Vries J, Van Der Spoel P, Mostert B, Martens JWM et al (2009) Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR. Breast Cancer Res Treat 118(3):455–468
Sinkala E, Sollier-Christen E, Renier C, Rosàs-Canyelles E, Che J, Heirich K et al (2017) Profiling protein expression in circulating tumour cells using microfluidic western blotting. Nat Commun 8:14622
Smallwood Sa, Lee HJ, Angermueller C, Krueger F, Saadeh H, Peat J et al (2014) Single-cell genome-wide bisulfite sequencing for assessing epigenetic heterogeneity. Nat Methods 11(8):817–820
Spits C, Le Caignec C, De Rycke M, Van Haute L, Van Steirteghem A, Liebaers I et al (2006) Whole-genome multiple displacement amplification from single cells. Nat Protocols 1(4):1965–1970
Stathopoulou A, Gizi A, Perraki M, Apostolaki S, Malamos N, Mavroudis D et al (2003) Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler syst. 9:5145–5151
Swennenhuis JF, Reumers J, Thys K, Aerssens J (2013) Terstappen LWMM. Efficiency of whole genome amplification of single circulating tumor cells enriched by CellSearch and sorted by FACS. Genome Med 5(11):106. PubMed PMID: PMC3978840
Thiele JA, Bethel K, Kralickova M, Kuhn P (2017) Circulating tumor cells: fluid surrogates of solid tumors. Annu Rev Pathol 12:419–447
Ting DT, Wittner BS, Ligorio M, Jordan NV, Ajay M, Miyamoto DT et al (2015) Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells david 8(6):1905–1918
Walter K, Holcomb T, Januario T, Du P, Evangelista M, Kartha N et al (2012) DNA methylation profiling defines clinically relevant biological subsets of non-small cell lung cancer. Clin Cancer Res 18(8):2360–2373
Wang Z, Wu W, Wang Z, Tang Y, Deng Y, Xu L et al (2016) Ex vivo expansion of circulating lung tumor cells based on one-step microfluidics-based immunomagnetic isolation. Analyst 141(12):3621–3625
Wit Sd, Dalum Gv, Lenferink ATM, Tibbe AGJ, Hiltermann TJN, Groen HJM et al (2015) The detection of EpCAM+ and EpCAM–circulating tumor cells. Sci Rep 5:12270
Yu M, Bardia A, Aceto N, Bersani F, Madden MW, Donaldson MC et al (2014) Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science 345(6193):216
Zhang L, Ridgway LD, Wetzel MD, Ngo J, Yin W, Kumar D et al (2013) The Identification and characterization of breast cancer CTCs competent for brain metastasis. Sci Transl Med 5(180):180ra48-ra48
Zhang Z, Shiratsuchi H, Lin J, Chen G, Reddy RM, Azizi E et al (2014) Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model. Oncotarget 5(23):12383–12397
Zhang Y, Tang Y, Sun S, Wang Z, Wu W, Zhao X et al (2015) Single-cell codetection of metabolic activity, intracellular functional proteins, and genetic mutations from rare circulating tumor cells. Anal Chem 87(19):9761–9768
Zheng Y, Miyamoto DT, Wittner BS, Sullivan JP, Aceto N, Jordan NV et al (2017) Expression of β-globin by cancer cells promotes cell survival during blood-borne dissemination. Nat Commun 8:14344
Zong C, Lu S, Chapman AR, Xie XS (2012) Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Science 338(6114):1622–1626
Acknowledgements
We would like to acknowledge Caroline Dive for her advice in writing this chapter. We would like to also acknowledge the help of the CR-UK Clinical and Experimental Pharmacology Group (C5759/A20971) for their support of this study, as well as the financial support from Medical Research Council Manchester Single Cell Research Centre (MR/M008908/1). FC is funded by Cancer-ID (115749-Cancer-ID), and SM is funded by AstraZeneca (D1330N00013).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chemi, F., Mohan, S., Brady, G. (2020). Circulating Tumour Cells in Lung Cancer. In: Schaffner, F., Merlin, JL., von Bubnoff, N. (eds) Tumor Liquid Biopsies. Recent Results in Cancer Research, vol 215. Springer, Cham. https://doi.org/10.1007/978-3-030-26439-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-26439-0_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-26438-3
Online ISBN: 978-3-030-26439-0
eBook Packages: MedicineMedicine (R0)